Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.
Clinical trial NCT06464614 · UNKNOWN
Trial details
- NCT number
- NCT06464614
- Sponsor
- The First Affiliated Hospital of Henan University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2025-08-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.